These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14588231)

  • 1. [Clinical significance of tumor content of epidermal growth factor receptor in breast cancer].
    Mulero M; Fernández Raigoso P; Vázquez J; Lamelas ML; Corte D; Allende MT; Rodríguez JC; Vizoso F
    Rev Esp Med Nucl; 2003 Nov; 22(6):386-94. PubMed ID: 14588231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic value of EGFR in invasive breast cancer.
    Quintela I; Corte MD; Allende MT; Vazquez J; Rodríguez JC; Bongera M; Lamelas M; Gonzalez LO; Vega A; García-Muñiz JL; Astudillo A; Vizoso F
    Oncol Rep; 2005 Dec; 14(6):1655-63. PubMed ID: 16273272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptors in human breast and endometrial carcinomas.
    Llorens MA; Bermejo MJ; Salcedo MC; Charro AL; Puente M
    J Steroid Biochem; 1989; 34(1-6):505-9. PubMed ID: 2626045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific oncological contribution of cathepsin D and pS2 in human breast cancer: their relationship with TNM status, estradiol receptors, epidermal growth factor receptor and neu amplification.
    Bolufer P; Torregrosa MD; Gomez L; Munarriz B; López JA; Asins E; Espinoza S; Vera F; Vazquez C; Guillem V
    Clin Chim Acta; 1996 Mar; 247(1-2):89-103. PubMed ID: 8920230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
    Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
    Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
    Pirinen R; Lipponen P; Syrjänen K
    Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.
    Koenders PG; Faverly D; Beex LV; Bruggink ED; Kienhuis CB; Benraad TJ
    Eur J Cancer; 1992; 28(2-3):693-7. PubMed ID: 1591096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytosolic concentrations of cathepsin D in 88 infiltrating ductal breast carcinomas having negative estrogen and progesterone receptors. Correlation with other clinical and biological parameters].
    Ruibal A; Arias J; Lapeña G; García Díez S; Tejerina A
    Rev Esp Med Nucl; 2001 Jun; 20(4):332-3. PubMed ID: 11940423
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between epidermal growth factor receptor and oestrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients in Kuwait.
    Nasralla MY; Paszko Z; Omar YT; Ali MA; al Jazzaf H; Padzik H; Temmim L
    Eur J Cancer; 1992; 29A(1):76-81. PubMed ID: 1445750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study.
    Xie M; Zhu X; Liu Z; Shrubsole M; Varma V; Mayer IA; Dai Q; Chen Q; You S
    PLoS One; 2012; 7(4):e35198. PubMed ID: 22496908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age.
    Zeillinger R; Kury F; Speiser P; Sliutz G; Czerwenka K; Kubista E
    Clin Biochem; 1993 Jun; 26(3):221-7. PubMed ID: 8392451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of snail in metaplastic breast carcinoma.
    Nassar A; Sookhan N; Santisteban M; Bryant SC; Boughey JC; Giorgadze T; Degnim A
    Diagn Pathol; 2010 Nov; 5():76. PubMed ID: 21110878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
    Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
    Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
    Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
    Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The variation and clinical significance of hormone receptors and Her-2 status from primary to metastatic lesions in breast cancer patients.
    Zhu YY; Si W; Ji TF; Guo XQ; Hu Y; Yang JL
    Tumour Biol; 2016 Jun; 37(6):7675-84. PubMed ID: 26687919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors.
    Valerón PF; Chirino R; Vega V; Falcón O; Rivero JF; Torres S; León L; Fernández L; Pestano J; Díaz-Chico B; Díaz-Chico JC
    Int J Cancer; 1997 Apr; 74(2):175-9. PubMed ID: 9133451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.